Search results
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 6 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 7 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, in an advanced clinical trial that included ...
National Academies Issue New Broad Definition of Long COVID
Medscape· 7 days agoA new broadly inclusive definition of long COVID from the National Academies of Sciences,...
CNBC Daily Open: Apple upgrades Siri with AI
CNBC· 7 days agoThe S&P 500 and the Nasdaq Composite inched to record highs ahead of the Federal Reserve's interest rate decision. Shares of Apple fell 1.9% after the iPhone maker delivered its long-awaited ...
Analysis | Court rejects abortion pill challenge, but what happens next?
Washington Post· 3 days agoWhat do you think is next in the fight over medication abortion? Today’s edition: Senate Republicans...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 5 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...